Physician
Moore Obgyn LLC
Moore Obgyn LLC was paid $23.15M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoMOORE OBGYN LLC
OXON HILL, MD 20745
OXON HILL, MD 20745
33aNPI1164857512assigned 09/04/2013
33bProvider typeObstetrics & Gynecology Physician
28Total paid$23.15M
24GClaims420,885
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Maryland
Rank by total paid#2 of 85
Median peer was paid$69K
This provider vs. median335×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,299 | $62K | |
| 2019 | 2,896 | $154K | |
| 2020 | 51,496 | $3.47M | |
| 2021 | 43,898 | $3.55M | |
| 2022 | 62,215 | $4.01M | |
| 2023 | 135,925 | $7.79M | |
| 2024incomplete | 123,156 | $4.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 73,864 | 47,903 | $5.51M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 21,944 | 16,308 | $2.38M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 8.4% | 50,364 | 7,604 | $1.94M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.5% | 10,231 | 8,847 | $1.04M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 3.8% | 11,773 | 8,653 | $882K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 3.5% | 1,054 | 926 | $811K |
| 76818 | 3.3% | 9,709 | 6,646 | $761K | |
| 76821 | 2.8% | 10,158 | 7,034 | $653K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2.6% | 4,370 | 3,704 | $607K |
| 87481 | 2.6% | 16,243 | 6,327 | $593K | |
| 76801 | 2.2% | 5,803 | 5,034 | $511K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.2% | 6,986 | 4,539 | $504K |
55 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 2.1% | 3,587 | $496K |
| 76820 | 1.9% | 10,747 | $430K | |
| 59410 | 1.7% | 517 | $396K | |
| 59514 | 1.5% | 412 | $350K | |
| 99385 | 1.5% | 3,077 | $350K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.3% | 3,436 | $307K |
| 59025 | Fetal non-stress test | 1.3% | 7,676 | $303K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 6,279 | $295K |
| 87529 | 1.2% | 9,772 | $266K | |
| 76830 | Ultrasound, transvaginal | 1.0% | 3,104 | $235K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 23,550 | $217K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,262 | $209K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 2,203 | $204K |
| 87640 | <1% | 9,356 | $201K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,191 | $193K |
| 59430 | <1% | 1,429 | $185K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,618 | $174K |
| 57454 | <1% | 1,240 | $161K | |
| 99223 | Prolong inpt eval add15 m | <1% | 971 | $156K |
| 87511 | <1% | 8,103 | $154K | |
| 87653 | <1% | 7,338 | $146K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,493 | $141K |
| 99386 | <1% | 1,023 | $135K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,437 | $131K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,111 | $128K |
| H1000 | Prenatal care, at-risk assessment | <1% | 3,939 | $124K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,644 | $118K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,539 | $98K |
| 87641 | <1% | 4,528 | $97K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 6,878 | $94K |
| 87500 | <1% | 4,876 | $92K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,290 | $67K |
| 81002 | <1% | 21,394 | $49K | |
| 81025 | <1% | 8,268 | $46K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,935 | $44K |
| 3015F | <1% | 2,585 | $42K | |
| 58300 | <1% | 247 | $16K | |
| 0503F | <1% | 900 | $16K | |
| 59515 | <1% | 19 | $15K | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 1,581 | $13K |
| 54150 | <1% | 176 | $12K | |
| 3008F | <1% | 2,517 | $9K | |
| 87210 | <1% | 2,561 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 468 | $7K |
| 99235 | <1% | 56 | $6K | |
| 81000 | <1% | 2,210 | $5K | |
| 11981 | <1% | 44 | $5K | |
| 58301 | <1% | 36 | $3K | |
| 2015F | <1% | 92 | $1K | |
| 57452 | <1% | 13 | $1K | |
| 90756 | <1% | 21 | $255.33 | |
| A4215 | Needle, sterile, any size, each | <1% | 3,513 | $148.21 |
| 0513F | <1% | 12 | $120.00 | |
| S0197 | Prenatal vitamins, 30-day supply | <1% | 99 | $41.14 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $11.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOORE, JAVAKA (CHIEF EXECUTIVE MANAGER)